View abstract

Cet abstract a été assigné à session AOB Free papers
TitreRobot assisted retinal vein cannulation for central retinal vein occlusion.
Abstract Nr.2079
ButTo evaluate the feasibility and safety of robot assisted retinal vein cannulation for central retinal vein occlusion (CRVO).
MéthodesPhase I study including patients with recent CRVO for vitrectomy with robot assisted retinal vein cannulation and intravessel infusion of ocriplasmin. Primary outcome is the occurrence of any serious adverse event (SAE) related to the cannulation or any possible technical failure. Secondary outcomes are change in visual acuity (VA), central macular thickness (CMT) and retinal circulation time measured with fluo-angiography.
RésultatsRetinal vein cannulation was successful in all 4 included eyes with an average duration of infusion of 5min55sec (±204sec). There were no SAEs except for one breakage of the needle tip intraoperatively. The broken part could be removed with endoforceps without causing clinical significant damage. On average, CMT decreased 584µm (±488µm) comparing pre- with two weeks postoperative. VA remained counting fingers (CF) in two eyes, decreased from LogMAR 0.4 to 1.3 in one eye and increased from CF to LogMAR 0.9 in the remaining eye.
ConclusionRobot assisted retinal vein cannulation is technically feasible and safe. Further research is needed to optimize case selection and functional outcome.
Conflit d'intérêtNon
Auteur 1
NomWILLEKENS
InitialesK
InstitutUZ Leuven
VilleLeuven
Auteur 2
NomGijbels
InitialesA
InstitutKULeuven
VilleLeuven
Auteur 3
NomSchoevaerdts
InitialesL
InstitutKULeuven
VilleLeuven
Auteur 4
NomSmits
InitialesJ
InstitutKULeuven
VilleLeuven
Auteur 5
NomJonckx
InitialesB
InstitutThromboGenics nv
VilleLeuven
Auteur 6
NomFeyen
InitialesJHM
InstitutThromboGenics nv
VilleLeuven
Auteur 7
NomReynaerts
InitialesD
InstitutKULeuven
VilleLeuven
Auteur 8
NomVander Poorten
InitialesE
InstitutKULeuven
VilleLeuven
Auteur 9
NomStalmans
InitialesP
InstitutUZ Leuven
VilleLeuven
top ^